Tuesday, June 13, 2017 2:37:00 PM
Additionally, I have no idea why everyone is harping on "FDA Approval." THERE WILL BE NO FDA APPROVAL. This is an FDA REGISTRATION. This just lists the product among many other products sold and what their ingredients are. Again, a savvy investor knows the difference in this play on words.
There is still a market here for the product - barring an unfavorable outcome from the trial. It's just not the opportunity the play on words suggests. Do your homework. Understand the difference. And understand what your real opportunities are with this stock.
Also, anyone else notice that the exact number of units they are manufacturing are the exact numbers of units Otiko was able to go out and sell based on his contract with Keough? Interesting.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM